The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Touchstone Innovations Plc

11 Sep 2017 09:41

RNS Number : 3581Q
Numis Securities Limited
11 September 2017
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Numis Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Touchstone Innovations PLC

 

(c) Name of the party to the offer with which exempt principal trader is connected:

Sponsor, Broker and Joint Financial Adviser to IP Group PLC

 

(d) Date dealing undertaken:

08/09/2017

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

 

Yes

IP Group PLC

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

3 1/33p ordinary

 

Purchase

N/A

N/A

N/A

3 1/33p ordinary

 

Sale

1,200

245.00 GBX

245.00 GBX

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

Date of disclosure:

11/09/2017

Contact name:

Jessica Meta

Telephone number:

0207 260 1330

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERGIGDCBSBBGRB
Date   Source Headline
26th Oct 20077:24 amPRNGBP30m Placing
27th Sep 20077:04 amRNSInvestment in EVO Electric
27th Sep 20077:00 amPRNFinal Results
24th Sep 20072:44 pmRNSThe Engineer Awards
12th Sep 20078:00 amPRNNotice of Preliminary Results
31st Aug 20079:00 amRNSInvestment in MVL
7th Aug 20079:00 amRNSionscope raises funds
3rd Aug 200710:25 amRNSInvestment in Veryan Medical
3rd Aug 20078:00 amRNSInvestment in Veryan Medical
1st Aug 20075:31 pmRNSInvestment in Nexeon Ltd
30th Jul 20078:00 amRNSInvestment in Acrobot Ltd
11th Jul 20079:37 amRNSInvestment in AML
6th Jul 20078:10 amRNSInvestment in NanoBioDesign
28th Jun 20077:02 amRNSInvestment in QuantaSol
25th Jun 200710:00 amRNSCall For Recycling Inventions
20th Jun 200711:21 amRNSInvestment in PolyTherics
14th Jun 20072:31 pmRNSInvestment in Midaz Lasers
6th Jun 20073:11 pmRNSPSE Wins MacRobert Award
5th Jun 200711:03 amRNSPSE - Awards Finalist
23rd May 20078:00 amRNSInvestment in IXICO Ltd
11th May 200710:00 amRNSInvestment in Veryan Medical
9th May 200710:04 amRNSMDi Licensing Deal
27th Apr 20077:01 amRNSLaunch of Funding Programme
27th Apr 20077:01 amRNSInterim Results
30th Mar 20078:00 amRNSInvestment in Cell Medica
27th Mar 200710:22 amRNSStormBio Licensing Deal
23rd Mar 20078:00 amRNSNotice of Results
22nd Mar 200711:53 amRNSHolding(s) in Company
16th Mar 200710:44 amRNSHolding(s) in Company
15th Mar 20079:00 amRNSIncubation of Stoneglass
12th Mar 20078:00 amRNSIonscope Sells First Products
8th Mar 20079:20 amRNSHolding(s) in Company
7th Mar 20078:00 amRNSChinese Strategic Partnership
13th Feb 20078:00 amRNSIncubation of Rubber-Regen
9th Feb 20073:05 pmRNSHolding(s) in Company
8th Feb 20072:58 pmRNSHolding(s) in Company
1st Feb 20077:00 amRNSInvestment in ATT Ltd
29th Jan 20077:01 amRNSInvestment in Circassia
25th Jan 200712:59 pmRNSResult of AGM
12th Jan 20079:00 amRNSInvestment in Equinox Pharma
21st Dec 200612:13 pmRNSTotal Voting Rights
18th Dec 20064:53 pmRNSHolding(s) in Company
8th Dec 20067:00 amRNSAnnual Report and Accounts
21st Nov 20067:01 amRNSDirector/PDMR Shareholding
16th Nov 20067:01 amRNSBAE Systems Contract
16th Nov 20067:01 amRNSFinal Results
2nd Nov 20068:00 amRNSImperial BioIncubator
26th Oct 20067:01 amRNSNotice of Results
23rd Oct 20064:17 pmRNSDisposal
18th Oct 20067:00 amRNSLow Carbon Seed Fund

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.